日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β

CD163 和 Tim-4 可识别受 TGF-β 空间调控的肠道驻留巨噬细胞。

Jayaraman, Vignesh; Prise, Ian E; Kästele, Verena; Tamburrano, Sabrina; Wemyss, Kelly; Bridgeman, Hayley M; Daw, Rufus H; Strangward, Patrick; Sanderson, Alfie; Cruickshank, Sheena M; Konkel, Joanne E; Chew, Christine; Yao, Chengcan; Anderson, C J; Priller, Josef; McColl, Barry; Munro, David A D; Martens, Liesbet; Scott, Charlotte L; Guilliams, Martin; Adamson, Antony D; Grainger, John R; Shaw, Tovah N

Serum sCD163 indicates disease severity and prognosis in sudden sensorineural hearing loss

血清sCD163水平可提示突发性感觉神经性听力损失的疾病严重程度和预后。

Xu, Ting; Miao, Huikai; Xie, Binli

Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma

免疫细胞聚类分析可识别出一种富含CD163⁺/CSF1R⁺巨噬细胞和中性粒细胞的表型,该表型具有独特的生物学特征,且在血管肉瘤中预后不良。

Simon, Adrian Georg; Grothey, Bastian; Lyu, Su Ir; Stahl, David; Schiffmann, Lars Mortimer; Bruns, Christiane Josephine; Eysel, Peer; Buettner, Reinhard; Ullrich, Roland Tillmann; Quaas, Alexander

Increased expression of CD36 and CD163 in clear cell renal cell carcinoma suggests an association between lipid transport and an "M2-like" macrophage phenotype.

透明细胞肾细胞癌中 CD36 和 CD163 表达增加,提示脂质转运与“M2 样”巨噬细胞表型之间存在关联。

CD163 at the crossroads: a viral-exploited immunomodulator

CD163 处于十字路口:一种被病毒利用的免疫调节剂

Tan, Jiayong; Cheng, Jie; Yang, Xiaohui; Zhang, Jian; Yang, Huaqiang

Combined assessment of ERO1A expression and CD163+ tumor-associated macrophage infiltration is superior to traditional assessment methods in predicting clear cell renal cell carcinoma prognosis

联合评估 ERO1A 表达和 CD163+ 肿瘤相关巨噬细胞浸润在预测透明细胞肾细胞癌预后方面优于传统评估方法。

Tianyu Hong #,Changjie Ren #,Hao Xiang #,Huaye Wu #,Yongwei Yu,Mierxiati Abudurexiti,Zhong Wang,Chao Wang #

CD163 and the FVIII/FXII ratio identified as novel biomarkers for early sepsis recognition

CD163 和 FVIII/FXII 比值被确定为早期脓毒症识别的新型生物标志物

Yan, Nan; Diao, Yanjun; Zhou, Shan; Lu, Linhe; Chen, Chu; Zhu, Bingbing; Jia, Jingyuan; Liu, Jiayun

Pigs with CD163 Mutation Conferred PRRSV Resistance

携带CD163突变的猪对猪繁殖与呼吸综合征病毒(PRRSV)具有抵抗力。

Wu, Changbao; Wang, Heyao; Zhang, Wei; Cheng, Miaomiao; Wang, Yang; Chen, Lian; Tang, Chao; Dai, Yanfeng; Zhang, Liping

Exploratory Study of Serum IL-22 and CD163+ Macrophages in Glioblastoma Multiforme

胶质母细胞瘤中血清IL-22和CD163+巨噬细胞的探索性研究

Aleksandrova, Elina; Ananiev, Julian; Vlaykova, Tatyana; Tacheva, Tanya; Petrova, Hristina; Valkanov, Stefan

Serum and urinary soluble CD163 in children with active lupus nephritis

活动性狼疮性肾炎患儿血清和尿液中可溶性CD163的水平

Owaidy, Rasha Hassan El; Ibraheem, Magid Ashraf; Alkhateeb, Yasmeen Hasan; Taha, Alaa Adel; Taha, Sara I; Sallam, Dina E